Skip to main content

Table 1 Patient characteristics.

From: Expression of ADAMs and Their Inhibitors in Sputum from Patients with Asthma

 

Patients with asthma

Control subjects

n

21

17

Mean age, years

34 (20–67)

29 (23–40)

Sex, M/F

16/5

7/10

FEV1, % predicted

88 (36–123)

92 (82–114)

FEV1, mL

3354 (1164–4920)

3670 (2430–4130)

PC20M, mg/mL

0.80 (0.3–6.2)

ND

Atopy, n

18/21

0/17

Therapy

21 NT

17 NT

  1. Values are expressed as mean (range); PC20M is expressed as geometric mean (range), NT indicates not treated (short-acting β2 agonists on demand); ND, not done; PC20M, methacholine concentration inducing a 20% fall in FEV1.